Literature DB >> 17591659

Ketamine effects on CNS responses assessed with MEG/EEG in a passive auditory sensory-gating paradigm: an attempt for modelling some symptoms of psychosis in man.

Peter H Boeijinga1, L Soufflet, F Santoro, R Luthringer.   

Abstract

Disturbances in integrative function have been consistentLy described in psychotic disorder; for instance, prepulse inhibition of the startle reflex (startle-PPI) which is a marker of sensory gating, is deficient in persons with schizophrenia. The N-methyl-D-aspartate antagonist ketamine produces in control subjects a spectrum of neurobehavioural symptoms like encountered in schizophrenia, and disrupts startle-PPI in animals. In the present study, we investigated in 12 healthy subjects whether ketamine would reduce sensory-gating in auditory responses at doses which produce psychotic symptoms. In a double-blind, crossover design loading doses of 0.024, 0.081 and 0.27 mg/kg or saline were employed, followed by maintenance infusion for 120 min. A passive paradigm has been developed which consisted in tone bursts, preceded or not by a (near-threshold) click at intervals of 100 ms or 500 ms. Brain electromagnetic activity imaging of the responses to sound stimuli has been carried out by way of a 148-channel magnetoencephalography-system. Actual evoked response amplitudes and underlying equivalent current dipole strengths have been compared to multi-electrode evoked potentials from the scalp. A click stimulus is capable to inhibit test responses under placebo at the 100 ms interval. During maintenance infusion of ketamine at steady-state (for >30 min) after 0.27 mg/kg, no such amplitude changes were observed anymore (p <0.05) and under these circumstances significant increases in Brief Psychiatric Rating scale and Scale for the Assessment of Negative Symptoms scores were evidenced (p < 0.001). Intermediate effects have been observed when the dose was lowered to 0.081 mg/kg. The present results have shown that ketamine may induce a psychotic-like clinical state associated with gating deficits in healthy subjects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17591659     DOI: 10.1177/0269881107077768

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  10 in total

Review 1.  Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits.

Authors:  Bernat Kocsis; Ritchie E Brown; Robert W McCarley; Mihaly Hajos
Journal:  CNS Neurosci Ther       Date:  2013-04-24       Impact factor: 5.243

2.  Effects of GABA-B receptor positive modulator on ketamine-induced psychosis-relevant behaviors and hippocampal electrical activity in freely moving rats.

Authors:  Jingyi Ma; L Stan Leung
Journal:  Psychopharmacology (Berl)       Date:  2017-07-29       Impact factor: 4.530

3.  A putative electrophysiological biomarker of auditory sensory memory encoding is sensitive to pharmacological alterations of excitatory/inhibitory balance in male macaque monkeys.

Authors:  William B Holliday; Kate Gurnsey; Robert A Sweet; Tobias Teichert
Journal:  J Psychiatry Neurosci       Date:  2018-05       Impact factor: 6.186

4.  Loudness- and time-dependence of auditory evoked potentials is blunted by the NMDA channel blocker MK-801.

Authors:  Tobias Teichert
Journal:  Psychiatry Res       Date:  2017-06-15       Impact factor: 3.222

5.  N-methyl-D-aspartate receptor antagonism impairs sensory gating in the auditory cortex in response to speech stimuli.

Authors:  Sara de la Salle; Joelle Choueiry; Judy McIntosh; Hayley Bowers; Vadim Ilivitsky; Verner Knott
Journal:  Psychopharmacology (Berl)       Date:  2022-03-28       Impact factor: 4.530

6.  Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine.

Authors:  L Elliot Hong; Ann Summerfelt; Robert W Buchanan; Patricio O'Donnell; Gunvant K Thaker; Martin A Weiler; Adrienne C Lahti
Journal:  Neuropsychopharmacology       Date:  2009-11-04       Impact factor: 7.853

7.  Ketamine-induced deficit of auditory gating in the hippocampus of rats is alleviated by medial septal inactivation and antipsychotic drugs.

Authors:  Jingyi Ma; Siew Kian Tai; L Stan Leung
Journal:  Psychopharmacology (Berl)       Date:  2009-08-05       Impact factor: 4.530

8.  Dual Effects of Limbic Seizures on Psychosis-Relevant Behaviors Shown by Nucleus Accumbens Kindling in Rats.

Authors:  Jingyi Ma; L Stan Leung
Journal:  Brain Stimul       Date:  2016-05-18       Impact factor: 8.955

Review 9.  Glutamatergic Deficits in Schizophrenia - Biomarkers and Pharmacological Interventions within the Ketamine Model.

Authors:  Moritz Haaf; Gregor Leicht; Stjepan Curic; Christoph Mulert
Journal:  Curr Pharm Biotechnol       Date:  2018       Impact factor: 2.837

10.  Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia: A Systematic Review and Meta-analysis.

Authors:  Katherine Beck; Guy Hindley; Faith Borgan; Cedric Ginestet; Robert McCutcheon; Stefan Brugger; Naomi Driesen; Mohini Ranganathan; Deepak Cyril D'Souza; Matthew Taylor; John H Krystal; Oliver D Howes
Journal:  JAMA Netw Open       Date:  2020-05-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.